Translations:Diabetes medication/20/en

From Azupedia
Revision as of 12:09, 4 February 2024 by FuzzyBot (talk | contribs) (Importing a new version from external source)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Typical reductions in glycated hemoglobin (A1C) values are 1.5–2.0%. Some examples are:

  • Rosiglitazone (Avandia): the European Medicines Agency recommended in September 2010 that it be suspended from the EU market due to elevated cardiovascular risks.
  • Pioglitazone (Actos): remains on the market but has also been associated with increased cardiovascular risks.
  • Troglitazone (Rezulin): used in 1990s, withdrawn due to hepatitis and liver damage risk.
Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Diabetes_medication/20/en&oldid=110564"